Accendra Health (ACH) EVP uses 966 shares to settle tax withholding

Rhea-AI Filing Summary

Accendra Health Inc. executive Heath H. Galloway reported a routine tax-related share disposition. On this Form 4, 966 shares of common stock were surrendered to the company at $3.04 per share to cover tax withholding tied to vesting of restricted stock. After this non-market transaction, Galloway directly holds 168,128 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Galloway Heath H

Role EVP,General Counsel & CorpSecy

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	966	$3.04	$3K

Holdings After Transaction: Common Stock — 168,128 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 966 shares Price per share: $3.04 per share Shares held after transaction: 168,128 shares

3 metrics

Tax-withholding shares 966 shares Shares surrendered to issuer for tax withholding on restricted stock vesting

Price per share $3.04 per share Value used for the 966-share tax-withholding disposition

Shares held after transaction 168,128 shares Direct common stock holdings after the tax-withholding disposition

Key Terms

tax withholding obligations, restricted stock, tax-withholding disposition

3 terms

tax withholding obligations financial

"satisfy tax withholding obligations in connection with vesting of restricted stock"

restricted stock financial

"in connection with vesting of restricted stock granted to the Reporting Person"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galloway Heath H

(Last) (First) (Middle)

ACCENDRA HEALTH INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP,General Counsel & CorpSecy

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		F		966(1)	D	$3.04	168,128	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Heath H. Galloway by Rosemarie France, POA	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ACCENDRA HEALTH INC/VA/ (ACH) report?

ACCENDRA HEALTH reported that executive Heath H. Galloway surrendered 966 common shares. The shares were delivered back to the company solely to satisfy tax withholding obligations from vesting restricted stock, not as an open-market sale.

Who is Heath H. Galloway in relation to ACCENDRA HEALTH (ACH)?

Heath H. Galloway is an officer of Accendra Health, serving as EVP, General Counsel and Corporate Secretary. The Form 4 shows his personal equity activity in the company’s common stock through a tax-related share disposition.

How many ACCENDRA HEALTH (ACH) shares were used for tax withholding?

A total of 966 shares of Accendra Health common stock were surrendered. These shares were delivered to the issuer to cover tax withholding obligations triggered by the vesting of previously granted restricted stock awards.

What price per share was used in the ACH insider tax-withholding transaction?

The tax-withholding disposition used a price of $3.04 per share. This value is shown on the Form 4 for the 966 surrendered common shares and is used to determine the amount applied toward tax obligations from restricted stock vesting.

How many ACCENDRA HEALTH (ACH) shares does Heath H. Galloway hold after this Form 4?

Following the tax-withholding share surrender, Heath H. Galloway directly holds 168,128 Accendra Health common shares. This figure reflects his ownership after the 966-share disposition back to the issuer for tax purposes.